Healthcare -
Biotechnology - NASDAQ - US
$ 1.6
1.3 %
$ 1.02 B
Market Cap
-7.43
P/E
GERN - GROSS PROFIT
Gross Profit GERN - Geron Corporation
75.7 M
LAST VALUE
1574.66%
2 YEAR CAGR
28.40%
5 YEAR CAGR
27.97%
10 YEAR CAGR